OpenEvidence, a medical information database, has recently achieved a remarkable valuation of $12 billion after securing a new round of funding led by Thrive and DST. This impressive growth means that the company's value has doubled since its last funding round in October. OpenEvidence is focused on providing essential medical data and insights, making it a valuable resource in the healthcare industry.
Despite facing competition from companies that create similar models, OpenEvidence continues ...
OpenEvidence, a medical information database, has recently achieved a remarkable valuation of $12 billion after securing a new round of funding led by Thrive and DST. This impressive growth means that the company's value has doubled since its last funding round in October. OpenEvidence is focused on providing essential medical data and insights, making it a valuable resource in the healthcare industry.
Despite facing competition from companies that create similar models, OpenEvidence continues ...